Index of 2002 Publications
-
Moses AV, Jarvis MA, Raggo C, Bell YC, Ruhl R, Luukkonen
BG, Griffith DJ, Wait CL, Druker BJ, Heinrich MC, Nelson
JA, Fruh K. A functional genomics
approach to Kaposi's sarcoma. Ann N Y Acad Sci.
2002 Dec;975:180-91.
PMID: 12538164
-
Yee KW, O'Farrell AM, Smolich BD,
Cherrington JM, McMahon G, Wait CL, McGreevey LS,
Griffith DJ, Heinrich MC.
SU5416 and SU5614 inhibit kinase
activity of wild-type and mutant FLT3 receptor tyrosine
kinase. Blood. 2002 Oct 15;100(8):2941-9.
Download
PDF
PMID: 12351406
-
Demetri GD, von Mehren M, Blanke
CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich
MC, Tuveson DA, Singer S, Janicek M, Fletcher JA,
Silverman SG, Silberman SL, Capdeville R, Kiese B,
Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher
CD, Joensuu H. Efficacy and
safety of imatinib mesylate in advanced gastrointestinal
stromal
tumors. N Engl J Med. 2002 Aug 15;347(7):472-80.
Download PDF
PMID:
12181401
-
Fletcher JA, Fletcher CD, Rubin
BP, Ashman LK, Corless CL, Heinrich MC. KIT
gene mutations in gastrointestinal stromal tumors:
more complex than previously recognized? Am
J Pathol. 2002 Aug;161(2):737-8; author reply 738-739
Download PDF
PMID:
12163398
-
Moses AV, Jarvis MA, Raggo C, Bell
YC, Ruhl R, Luukkonen BG, Griffith DJ, Wait CL, Druker
BJ, Heinrich MC, Nelson JA, Fruh K. Kaposi's
sarcoma-associated herpesvirus-induced upregulation
of the c-kit proto-oncogene, as identified by gene
expression profiling, is essential for the transformation
of endothelial cells. J Virol. 2002 Aug;76(16):8383-99.
PMID:
12134042
-
Heinrich MC, Rubin BP, Longley
BJ, Fletcher JA. Biology and
genetic aspects of gastrointestinal stromal tumors:
KIT activation and cytogenetic alterations.
Hum Pathol. 2002 May;33(5):484-95. Review.
Download
PDF
PMID:
12094373
-
Dematteo RP, Heinrich MC, El-Rifai
WM, Demetri G. Clinical management
of gastrointestinal stromal tumors: before and after
STI-571. Hum Pathol. 2002 May;33(5):466-77.
Download
PDF
PMID:
12094371
-
Corless CL, McGreevey L, Haley
A, Town A, Heinrich MC. KIT
mutations are common in incidental gastrointestinal
stromal tumors one centimeter or less in size. Am
J Pathol. 2002 May;160(5):1567-72.
Download
PDF
PMID:
12000708
-
Dai MS, Chevallier N, Stone S,
Heinrich MC, McConnell M, Reuter T, Broxmeyer HE,
Licht JD, Lu L, Hoatlin ME.
The effects of the Fanconi anemia
zinc finger (FAZF) on cell cycle, apoptosis, and proliferation
are differentiation stage-specific. J Biol
Chem. 2002 Jul 19;277(29):26327-34. Epub 2002 May
01.
Download
PDF
PMID:
11986317
-
Heinrich MC, Blanke CD, Druker
BJ, Corless CL. Inhibition of
KIT tyrosine kinase activity: a novel molecular approach
to the treatment of KIT-positive malignancies.
J Clin Oncol. 2002 Mar 15;20(6):1692-703.
Download PDF
PMID:
11896121
-
Mauro MJ, O'Dwyer M, Heinrich
MC, Druker BJ. STI571: a paradigm
of new agents for cancer therapeutics.
J Clin Oncol. 2002 Jan 1;20(1):325-34.
Download PDF
PMID:
11773186
-
Heinrich,M.C.; Corless,C.L.; Blanke,C.D.;
Demetri ,G.; Joensuu,H.; von Mehren,M.; McGreevey,L.;
Wait,C.L.; Griffith,D.; Chen,C.J.; Haley,A.; Kiese,B.;
Druker,B.; Roberts,P.J.; Eisenberg,B.L.; Singer,S.;
Silberman,S.; Dimitrijevic,S.; Fletcher,C.D.; Fletcher,J.A.
KIT mutational status predicts
clinical response to STI571 in patients with metastatic
gastrointestinal stromal tumors (GISTs). Proceedings
of the American Society for Clinical Oncology (ASCO),
vol 21, 2a, 2002 Abstract.
Click
Here to View Abstract at ASCO.org
-
Christopher D.M. Fletcher, M.D.,
Frc.Path, Jules J. Berman, M.D.,Ph.D, Christopher
L. Corless, M.D.,Ph.D., Fred Gorstein, M.D., Jerzy
LaSota, M.D., B. Jack Longley, M.D., Markku Miettinen,
M.D, Timothy J. O'Leary, M.D,Ph.D, Barry Shmookler,
M.D., Brian P. Rubin, M.D, Ph.D., Leslie H. Sobin,
M.D., and Sharon W. Weiss, M.D. Diagnosis
of Gastrointestinal Stromal Tumors: A Consensus Approach.
Human Pathology. Volume 33, No. 5 (May 2002).
Download PDF
PMID:
12094370